M Suffness

2.1k total citations
19 papers, 1.4k citations indexed

About

M Suffness is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, M Suffness has authored 19 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in M Suffness's work include Cancer Treatment and Pharmacology (5 papers), Phytochemistry and Bioactive Compounds (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). M Suffness is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Phytochemistry and Bioactive Compounds (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). M Suffness collaborates with scholars based in United States, Malaysia and United Kingdom. M Suffness's co-authors include Christian Goetz, J. E. Anderson, Jerry L. McLaughlin, David S. Reiner, Frances D. Gillin, M. Hernández, Leon H. Zalkow, Jan A. Gliński, R. D. HAUGWITZ and V. L. Narayanan and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

M Suffness

18 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Suffness United States	15	590	352	330	201	150	19	1.4k
Nathaniel H. Greenberg United States	6	536 0.9×	158 0.4×	261 0.8×	191 1.0×	86 0.6×	9	1.1k
Yasuyuki Ohtake Japan	25	1.3k 2.2×	284 0.8×	182 0.6×	97 0.5×	241 1.6×	48	2.3k
Yung-Chi Cheng United States	27	1.3k 2.1×	207 0.6×	534 1.6×	328 1.6×	34 0.2×	43	2.2k
Harri G. Ramjit United States	16	548 0.9×	128 0.4×	114 0.3×	172 0.9×	40 0.3×	47	1.1k
Edward G. Miller United States	18	658 1.1×	250 0.7×	122 0.4×	336 1.7×	118 0.8×	31	1.5k
Michel Koch France	28	1.3k 2.3×	613 1.7×	183 0.6×	1.3k 6.3×	60 0.4×	151	2.9k
Mаhmoud Youns Egypt	27	1.0k 1.8×	328 0.9×	195 0.6×	610 3.0×	223 1.5×	49	2.3k
Mukram Mohamed Mackeen Malaysia	20	1.1k 1.9×	529 1.5×	192 0.6×	194 1.0×	165 1.1×	46	1.8k
Hong‐Chun Liu China	28	1.5k 2.5×	215 0.6×	212 0.6×	315 1.6×	51 0.3×	96	2.3k
Sahapat Barusrux Thailand	19	520 0.9×	334 0.9×	102 0.3×	160 0.8×	186 1.2×	35	1.3k

Countries citing papers authored by M Suffness

Since Specialization

Citations

This map shows the geographic impact of M Suffness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Suffness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Suffness more than expected).

Fields of papers citing papers by M Suffness

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Suffness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Suffness. The network helps show where M Suffness may publish in the future.

Co-authorship network of co-authors of M Suffness

This figure shows the co-authorship network connecting the top 25 collaborators of M Suffness. A scholar is included among the top collaborators of M Suffness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Suffness. M Suffness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Suffness, M. (1995). Is taxol a surrogate for a universal regulator of mitosis?. PubMed. 8(5). 867–78. 15 indexed citations

Suffness, M, et al.. (1995). The National Cooperative Natural Products Drug Discovery Group (NCNPDDG) and International Cooperative Biodiversity Group (ICBG) Programs. International Journal of Pharmacognosy. 33(sup1). 5–16. 14 indexed citations

O'Dwyer, P J, James D. Moyer, M Suffness, et al.. (1994). Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.. PubMed. 54(3). 724–9. 44 indexed citations

Boyd, Michael R., et al.. (1994). ChemInform Abstract: Role of Plants in the National Cancer Institute Drug Discovery and Development Program. ChemInform. 25(20). 17 indexed citations

Arbuck, Susan G., Michaele C. Christian, Jason S. Fisherman, et al.. (1993). Clinical development of Taxol.. PubMed. 11–24. 50 indexed citations

Arbuck, Susan G., H. William Strausś, Eric K. Rowinsky, et al.. (1993). A reassessment of cardiac toxicity associated with Taxol.. PubMed. 117–30. 134 indexed citations

Anderson, J. E., Christian Goetz, Jerry L. McLaughlin, & M Suffness. (1991). A blind comparison of simple bench‐top bioassays and human tumour cell cytotoxicities as antitumor prescreens. Phytochemical Analysis. 2(3). 107–111. 211 indexed citations

Suffness, M, et al.. (1990). Assays related to cancer drug discovery. Medical Entomology and Zoology. 6. 71–133. 428 indexed citations

Deutsch, Howard M., Jan A. Gliński, M. Hernández, et al.. (1989). Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity. Journal of Medicinal Chemistry. 32(4). 788–792. 193 indexed citations

10.

Grem, Jean L., Bruce D. Cheson, Susan A. King, Brian Leyland‐Jones, & M Suffness. (1988). Cephalotaxine Esters: Antileukemic Advance or Therapeutic Failure?. JNCI Journal of the National Cancer Institute. 80(14). 1095–1103. 28 indexed citations

11.

Suffness, M, et al.. (1987). Indicine N-oxide: clinical use of a pyrrolizidine alkaloid.. PubMed. 71(5). 517–23. 6 indexed citations

12.

Bray, Dorothy, Peter Boardman, Melanie J. O’Neill, et al.. (1987). Plants as a source of antimalarial drugs 5. Activities of Ailanthus altissima stem constituents and of some related quassinoids. Phytotherapy Research. 1(1). 22–24. 29 indexed citations

13.

King, Susan A., et al.. (1986). Homoharringtonine--perspectives on an active new natural product.. Journal of Clinical Oncology. 4(10). 1563–1568. 25 indexed citations

14.

O’Neill, Melanie J., Dorothy Bray, Peter Boardman, et al.. (1986). Plants as sources of antimalarial drugs: in vitro antimalarial activities of some quassinoids. Antimicrobial Agents and Chemotherapy. 30(1). 101–104. 69 indexed citations

15.

Pettit, George R., Gordon M. Cragg, & M Suffness. (1986). ChemInform Abstract: Phyllanthostatin 1‐Phyllanthoside Orthoacid Rearrangement.. Chemischer Informationsdienst. 17(19). 1 indexed citations

16.

Suffness, M, et al.. (1985). Stability of the in vivo P388 leukemia model in evaluation of antitumor activity of natural products.. PubMed. 69(6). 683–5.

17.

Gillin, Frances D., David S. Reiner, & M Suffness. (1982). Bruceantin, a potent amoebicide from a plant, Brucea antidysenterica. Antimicrobial Agents and Chemotherapy. 22(2). 342–345. 103 indexed citations

18.

Douros, John & M Suffness. (1981). New Natural Products Under Development at the National Cancer Institute. Recent results in cancer research. 76. 153–175. 21 indexed citations

19.

Kupchan, S. Morris & M Suffness. (1968). Veratrum alkaloids. LIV. Stereochemistry of jervine and related alkaloids. Journal of the American Chemical Society. 90(10). 2730–2731. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact